Evid Based Nurs 4:14 doi:10.1136/ebn.4.1.14
  • Treatment

On demand use of β2-agonists led to better asthma control than regular use in moderate to severe asthma

 QUESTION: In patients with moderate to severe asthma, is on demand β2-agonist inhalation as effective and safe as regular use?


Randomised {allocation concealed}*, blinded (outcome assessors and statistician), crossover trial with 24 weeks of follow up for each treatment condition.


Outpatient clinic at Düsseldorf University Medical Centre, Germany.


80 patients (mean age 48 y, 74% women) with moderate to severe asthma on regularly scheduled β2-agonist (minimum daily intake of 6 puffs) and corticosteroid inhalation for ≥2 years. Exclusion criteria were non-respiratory illnesses or pregnancy. 73 patients (91%) completed the study.


Two 24 week periods in which patients were allocated to on demand inhalation (salbutamol or fenoterol) or regular use β2-agonists (2 inhalations 4 times daily plus salbutamol or fenoterol on demand) and crossed over to the other regimen after completion of the first …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article